www.spotsndots.com

The forecast assumes that effective vaccines will be widely available by mid-2021, although full availability is not expected until 2022. Full-year 2020 sales are expected to be down 15% from the levels achieved in 2019. IHS Markit remains cautious on recovery prospects, with key markets likely to experience differing demand cycles. ................
................

In order to avoid copyright disputes, this page is only a partial summary.